HUTCHMED (China) (HMDCF) Revenue Growth (1y) (2016 - 2021)

HUTCHMED (China) (HMDCF) Revenue Growth (1y) (2016 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 2.34%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.91%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.62%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 6.98%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 42.25%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 14.92%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -87.11%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 3.77%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.23%
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -38.91%
Mar 31, 2021 58.15%
Jun 30, 2020 148.05%
Mar 31, 2020 -1.15%
Dec 31, 2019 0.44%
Sep 30, 2019 -16.09%
Jun 30, 2019 0.36%
Mar 31, 2019 -0.32%
Jun 30, 2016 0.77%